MRFR Year End Sale
Lymphedema Treatment Market Research Report - Forecast till 2030

Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) - Forecast to 2030

ID: MRFR/HC/6968-HCR | December 2022 | Region: Global | 110 Pages         

Lymphedema Treatment Market

The Lymphedema Treatment Market is evaluated to grow at a CAGR of 8.80%. Therefore, the market value is evaluated to expand up to USD 731 Million By 2030

Segmentation

By Type Primary Lymphedema Secondary Lymphedema
By Affected Area Lower Extremity Upper Extremity Genitalia
By Treatment Compression Devices & Bandaging Laser Therapy Drug Therapy & Surgery
By End-User Hospitals and clinics Clinical Research Organizations Research & Academic Institutes

Key Players

  • Mego Afek Ltd. (US)
  • Bio Compression Systems Inc. (US)
  • SIGVARIS (Switzerland)
  • Herantis Pharma PLC (Finland)
  • 3A Health Care (Italy)
  • Wright Therapy Products (Germany)
  • Tactile Systems Technology Inc. (US)
  • Lohmann & Rausher (Germany)
  • Juzo (Germany)
  • 3M (US)

Drivers

  • Increasing cancer cases
  • Favorable reimbursement policies
Speak to Analyst Request a Free Sample

Market Overview


The lymphedema treatment market is anticipated to reach USD 731 Million by 2030 at 8.80% CAGR during the forecast period 2022-2030. Lymphedema happens when the lymph fluids accumulate on the fatty tissues underneath the skin.  This is mainly caused due to the irregular flow in the lymphatic system. It is observed in the legs, arms as well as feet.


People across the world are getting affected by the disease. As a result, the demand for effective treatment is also increasing. Therefore, the Lymphedema Treatment Market Analysis suggests that the market will grow at a significant rate in the forecast period. Asia-Pacific region is evaluated to witness the fastest CAGR in the forecast period.


COVID-19 Analysis


The coronavirus disease caused a massive disruption in the Lymphedema Treatment Market Growth. The businesses in the healthcare industry such as pharmaceuticals, biochemicals, etc. academic and research institutes were highly affected. Hospitals across the world were focused on treating affected patients with coronavirus. As a result, the patients suffering from other diseases were highly affected. Along with that, the lockdown disrupted the supply chain and disrupted the market.


Market Dynamics


Market Drivers


The Lymphedema Treatment Market is expected to grow at a significant rate due to the support of various drivers such as increasing cases of cancer diseases. Also, the supportive initiatives by the government and reimbursement policies will be favorable for market growth.


Restraints


The high costs related to surgeries and treatments are considered to be a major restraint for the Lymphedema Treatment Market Growth.


Opportunities


Several initiatives by the key players such as mergers, acquisitions, partnerships, etc. are anticipated to offer new opportunities. Along with that, the increasing expenditure for healthcare and development and research will further boost the market.


Challenges


Despite various technological advancements, there is still no permanent solution to treat lymphedema. Hence, it can hinder market growth in the upcoming years. 


Cumulative Analysis


Lymphedema Treatment market size is anticipated to grow exponentially over the forecast period. The drivers such as rapid development and favorable policies by the government are anticipated to improve the market growth.


Value Chain Analysis


The increasing cases of various cancer diseases are one of the crucial reasons for the market growth. Apart from that, the development by key players and rising Lymphedema Treatment Market Trends will simultaneously improve the value chain of the market in the forthcoming years.


Market Segmentations


The Lymphedema Treatment Market Size is divided into different segments such as treatment, type, the affected area, and end-user. Based on treatment, the market is divided into Bandages and Compressing Devices, Drug Therapy, Laser Therapy, Surgery, and Others. Laser therapy is considered to grow at the fastest rate in the upcoming years. Compression devices are the pumps that are connected to the sleeve and are wrapped across the affected area. Furthermore, the bandaging helps to get refilled with liquid. Lastly, surgery and drug therapy are opted at the lowest rate rates.


Based on type, the Lymphedema Treatment Market is segmented into Secondary Lymphedema, and Primary Lymphedema.  Primary lymphedema is caused due to the development of an abnormal cluster of lymph. It mainly happens during old age or birth. Secondary lymphedema is caused due to the damaging of lymph caused by cancer treatment such as radiation therapy, surgery, etc.


Based on the affected area, the market is bifurcated into Upper Extremity, Lower Extremity, and Genitalia. The upper extremity is one of the complicated diseases and the lower extremity area involves swelling of feet, legs, and ankles. Overall, the genitalia sub-segment holds the least share in the market.


Based on end-user, the Lymphedema Treatment Market is divided into Clinics and Hospitals, Academic and Research Institutes, Clinical Research Organisations. The sub-segment of clinics and hospitals are evaluated to hold the largest share in the market. Furthermore, the research organization and academic and research institutes are evaluated to have significant growth.


Regional Analysis


Regionally, the Lymphedema Treatment Market is segmented into Asia-Pacific, Europe, Americas, and Africa, and the Middle East. The Americas region is estimated to have the largest share in the market. Mainly, due to the increased cases of cancer and the emergence of various key players, the region is expected to have a significant share.


Secondly, Europe is evaluated to enjoy the second-largest Lymphedema Treatment Market Share. The increasing expenditure for healthcare and supportive initiatives by the government for lymphedema treatment are the crucial reasons for the exceptional growth.


Thirdly, the Asia-Pacific region is anticipated to hold the largest share in the market. Countries such as India and China are developing at a rapid pace which is estimated to have a positive effect on the Lymphedema Treatment Market Growth.


Additionally, Africa and the Middle East region are expected to have the least share in the market. The low development of healthcare and strict regulations by the government is restraining the market growth in this region.


Competitive Landscape


The key players are crucial for improving the market value. They do various strategic developments such as opportunities, drivers, challenges, etc. to improve their business withhold. Some of the crucial players in the Lymphedema Treatment Market are as follows.



  • Mego Afek Ltd. (US)

  • Bio Compression Systems Inc. (US)

  • SIGVARIS (Switzerland)

  • Herantis Pharma PLC (Finland)

  • 3A Health Care (Italy)

  • Wright Therapy Products (Germany)

  • Tactile Systems Technology Inc. (US)

  • Lohmann & Rausher (Germany)

  • Juzo (Germany)

  • 3M (US)

  • Cardinal Health (US)

  • Huntleigh Healthcare Limited (UK)

  • Koya Medical (US)

  • Avet Pharmaceuticals (US)

  • AIROS Medical Inc. (US)

  • Convatec (UK)


Recent Developments


No Recent Developments were found.


Report Overview


The overview of the Lymphedema Treatment Market Outlook is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation


The report score is to provide substantial information about the Lymphedema Treatment Market Forecast. It covers information such as market growth, drivers, key players, developments, and many more. The information provided in this report is collected from various secondary and primary sources.



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2017-2020


Segmentation


By Type



  • Secondary Lymphedema

  • Primary Lymphedema


By Treatment



  • Bandages and Compressing Devices

  • Drug Therapy

  • Laser Therapy

  • Surgery

  • Others


By Affected Area



  • Upper Extremity

  • Lower Extremity

  • Genitalia


By End-User



  • Clinics and Hospitals

  • Academic and Research Institutes

  • Clinical Research Organisations


By Region



  • Asia-Pacific

  • Americas

  • Europe

  • Africa and the Middle East



Report Scope:

Report Attribute/Metric Details
  Market Size   731 Million
  CAGR   8.80%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Affected Area, Treatment and End-User
  Geographies Covered    North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   3A Health Care (Italy), Bio Compression Systems, Inc. (US), Devon Medical Products (US), HERANTIS PHARMA PLC (Finland), Lohmann & Rauscher (Germany), Mego Afek Ltd (US), SIGVARIS (Switzerland), Tactile Systems Technology Inc. (US), Wright Therapy Products (BSN Medical) (Germany)
  Key Market Opportunities   Increased research & development in the market is estimated to influence the commercialization in the market
  Key Market Drivers

  • Increasing cancer cases
  • Favorable reimbursement policies
  • Favorable reimbursement policies
  • Strong pipeline in the market
  • Government support


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    lymphedema treatment market is projected grow at approximately 8.80% CAGR during the assessment period (2022-2030).

    The valuation of the global lymphedema treatment market is estimated to increase to USD 731 MN by the end of 2030.

    Favorable reimbursement policies, Strong pipeline in the market, and Government support are the major tailwinds pushing the growth of the global lymphedema treatment market.

    North America holds the largest share in the global lymphedema treatment market, followed by Europe and the Asia Pacific, respectively.

    3A Health Care (Italy), Bio Compression Systems, Inc. (US), Devon Medical Products (US), Herantis Pharma Plc (Finland), Lohmann & Rauscher (Germany), Mego Afek Ltd (US), SIGVARIS (Switzerland), Tactile Systems Technology Inc. (US), and Wright Therapy Products (Germany), are some of the major players operating in the global lymphedema treatment market.